Implementation of eye screening programmes for patients with diabetes: a systematic map of evidence from five countries.

内容摘要

Diabetic retinopathy is a severe diabetes complication that can cause blindness. The United Kingdom's pioneering diabetic eye screening programme has decreased blindness by early detection and treatment. Enhancing diabetic eye screening uptake requires a deeper understanding of the programme implementation. This study aimed to develop a logic model depicting diabetic eye screening programme implementation and to systematically map evidence on the implementation of diabetic eye screening in the United Kingdom and countries with similar health systems: Australia, Canada, Ireland and New Zealand. A logic model was coproduced with UK National Screening Committee members and public coproducers with living experience of diabetic eye screening, informed by existing models and group knowledge. We searched 14 discipline-focused bibliographic databases, 3 academic search engines (Google Scholar, Bielefeld Academic Search Engine and OpenAlex) and targeted websites that covered the time frame up to December 2023. Eligible studies, from 2003 onwards, involved diabetic eye programme implementation in the target countries, covering a range of outcomes. Data extracted were publication year, study location (country), aim of study, study evaluation design, reported data (effectiveness outcomes, implementation outcomes, views/experiences data, observational data or data on resources required), study population, screening stage, intervention strategies and health inequality considerations. Findings are displayed as an interactive evidence map and searchable database. The coproduced logic model depicted factors that could be mapped: screening stage, intervention strategy and evidence type as well as 'black box' factors that would require an in-depth synthesis to address: points for improvement and mechanisms of action. One hundred and thirty-three records were included the interactive map. The largest subset of studies provided information relevant to the entire screening pathway or multiple parts of this system (n = 85), followed by interventions relating to delivery of the eye screening appointment (n = 36), while the fewest studies focused specifically on processes for identifying people eligible for screening. Few studies used experimental designs to evaluate the intervention effectiveness, and there were relatively few studies assessing how well interventions were implemented. Of the studies that reported the evaluation of some form of intervention, the most common type was environmental restructuring of the social and/or physical context (n = 40). The most common data types were observational (e.g. audit studies; n = 69) and views or experiences (n = 51). Most studies provided data that can contribute to tackling health inequalities (n = 91). We identified 328 additional records that met the general inclusion criteria but were not included in the map for pragmatic reasons (e.g. the record only presented a conference abstract or brief report with limited detail about the study). Thus, the map reflects a subset of the evidence base. Also, the review's focus on five countries may omit valuable insights from elsewhere. A substantial body of evidence on diabetic eye programme implementation exists across five countries. However, evidence gaps remain, as certain process stages align with specific study types and data, highlighting areas for further research. The logic model and map may be useful for exploring ways to improve implementation of the programme. Future evidence syntheses could analyse subsets of studies on health inequalities, implementation experiences and outcomes, quality assurance processes or the underlying mechanisms of interventions. Primary research could address the various gaps in the evidence base. This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Evidence Synthesis programme as award number NIHR159996. Diabetic retinopathy is a serious eye condition caused by diabetes that can lead to loss of sight without detection and treatment. In the United Kingdom, people with diabetes are offered regular screening to catch the problem early and prevent blindness. Currently, screening attendance falls short of national guidelines among different groups, especially people with unequal access to health care. The United Kingdom National Screening Committee asked the team to review the evidence about how screening programmes are delivered and where improvements are needed. We looked at what research has been done in the United Kingdom and countries with similar healthcare systems (Australia, Canada, New Zealand and Ireland). Our team included researchers and public collaborators with lived experience of diabetic eye screening, and we consulted with the United Kingdom National Screening Committee. We searched through databases and websites to find as many relevant studies as we could from 2003 to 2024. We then looked at the studies to see what aspects of screening they covered, who the study involved and what types of questions they examined. We found 133 studies that were relevant and developed an evidence map (a form of visual summary of studies) to show what we learned. Most studies looked at the entire screening process; some focused on what happens during the appointment and few studies talked about the screening invite stage. Many studies explored aspects of unequal access to health care, and they often examined people’s views and experiences. The team found more relevant studies but did not include them, usually, because they did not have enough detail about what methods they used. As such, our findings might not show the whole picture. Also, we only looked at five countries, so we might have missed valuable ideas for improvement from other countries. The evidence map shows that there is a lot of research on how to provide diabetic eye screenings, but there are still many areas of this topic that are unexplored and where research is needed.